[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"status-days":3,"stock-4119":32,"stock-themes-4119":139},[4,18],{"date":5,"taiex_close":6,"taiex_chg":7,"taiex_chg_pct":8,"advancers":9,"decliners":10,"unchanged":11,"stocks":12,"turnover_sum":13,"margin_balance":14,"margin_chg":15,"short_balance":16,"short_chg":17},"2026-10-12",49301.96,-11.480000000003201,-0.00023279657634922568,868,916,158,1971,1044705369816,9174215,2895,175930,1165,{"date":19,"taiex_close":20,"taiex_chg":21,"taiex_chg_pct":22,"advancers":23,"decliners":24,"unchanged":25,"stocks":26,"turnover_sum":27,"margin_balance":28,"margin_chg":29,"short_balance":30,"short_chg":31},"2026-10-13",48341.31,-960.6500000000015,-0.019485026558781926,444,1337,161,1975,1306098703553,9070158,-104057,168869,-7061,{"profile":33,"snapshot":50,"data_version":138},{"code":34,"name":35,"full_name":36,"market":37,"kind":38,"industry":39,"listed_date":40,"chairman":41,"president":42,"capital":43,"shares":44,"founded_date":45,"website":46,"address":47,"english_name":48,"dividend_frequency":49},"4119","旭富","旭富製藥科技股份有限公司","sii","stock","生技醫療業","2004-01-07","翁維駿","周文智",1195086340,119508634,"1987-09-18","www.sci-pharmtech.com.tw","桃園市蘆竹區濱海里13鄰海湖北路309巷61號","SCI","每年",{"code":34,"name":35,"market":37,"kind":38,"industry":39,"close":51,"chg":52,"chg_pct":53,"ret_5d":54,"ret_20d":55,"volume":56,"turnover":57,"mcap":58,"signals":59,"as_of":19,"ref_price":63,"ret_60d":64,"ret_ytd":65,"open":66,"high":67,"low":68,"pe":69,"pb":70,"dy":71,"foreign_net_1d":72,"foreign_net_5d":73,"trust_net_1d":54,"trust_net_5d":54,"dealer_net_1d":54,"dealer_net_5d":74,"foreign_holding_pct":75,"margin_balance":76,"margin_chg":77,"short_balance":54,"short_chg":54,"large_holder_pct":78,"large_holder_chg_1w":79,"large_holder_chg_4w":80,"holders_date":81,"high_52w":82,"low_52w":83,"rev_period":84,"rev_yoy":85,"eps_period":86,"eps":87,"spark":88},54.3,-1.4000000000000128,-0.02513464991023362,0,-0.06217616580310892,190020,10329112,6489318826.2,[60,61,62],"rev_yoy","rev_yoy_3m","foreign_buy_5d",55.70000000000001,0.15531914893617005,0.13397366722060733,54.5,55,53.8,108.6,1.22,1.38,-1985,111659,914,5.31,473,-43,45.03,-0.030000000000001137,0.00999999999999801,"2026-10-09",60.8,39.6,"2026-09",33.05,"2026-Q2",-0.10749844990364718,[89,90,91,92,93,94,95,96,97,98,99,100,98,101,102,103,104,105,106,106,107,108,109,110,111,109,94,112,113,114,115,116,117,118,119,119,120,68,121,122,123,124,125,126,127,128,129,130,131,132,116,133,134,135,51,136,137,115,134,51],46.35,46.7,48.4,49.8,49.15,51.9,51.7,50.1,49.55,48,47.35,48.75,48.6,48.65,51.6,52.5,52.9,55.1,53,53.4,52.3,52,52.4,51.8,52.2,53.3,54.4,55.4,56.3,55.9,56.1,54.6,57.7,57.9,58.3,58,59.6,59.7,59.2,58.2,57.3,57.4,56.8,56.7,55.5,55.7,55.6,53.2,53.6,"20261013-25697c",[140],{"theme":141,"segment":149,"tier":150,"role":151,"relevance":152,"note":153,"peers":154,"upstream":179,"downstream":180},{"id":142,"slug":143,"name":144,"category":145,"ret_1d":148},56,"cdmo-generics","CDMO 與學名藥",{"slug":146,"name":147},"biotech","生技醫療",-0.010119884584519796,"原料藥","upstream","niche","high","原料藥與中間體",[155,167],{"code":156,"name":157,"role":158,"relevance":152,"note":159,"industry":39,"close":160,"chg_pct":161,"ret_5d":162,"ret_20d":163,"mcap":164,"turnover":165,"signals":166},"1789","神隆","leader","高活性原料藥",19.4,-0.010204081632653295,0.048648648648648596,0.043010752688172005,15340340906.8,8210821,[60,62],{"code":168,"name":169,"role":151,"relevance":152,"note":170,"industry":39,"close":171,"chg_pct":172,"ret_5d":173,"ret_20d":174,"mcap":175,"turnover":176,"signals":177},"4746","台耀","原料藥與委託製造",47.6,-0.011422637590861928,0.0052798310454065245,0.024757804090419944,5724183838.8,30275715,[60,61,178,62],"eps_yoy",[],[181],{"id":67,"slug":182,"name":183,"category":184,"ret_1d":185},"new-drugs","新藥研發",{"slug":146,"name":147},-0.02604453744683346]